about
Interventions to improve the appropriate use of polypharmacy for older peopleMinimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycleReview of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.Systems to identify potentially inappropriate prescribing in people with advanced dementia: a systematic review.Medication reviews.What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.Patient barriers to and enablers of deprescribing: a systematic review.Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness.Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria.Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.Factors influencing deprescribing habits among geriatricians.People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe.Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
P2860
Q24193171-105B8E5F-E91D-4FE2-AA29-920C07C8419CQ33949454-1FA61873-ECEC-45A2-AF73-563D37C407CFQ34554391-5F18BA0F-D73A-40FF-ACB8-50714A920CD9Q35894338-87969025-7A60-4684-90EB-D935B38974F8Q36035333-7AC97498-1CA9-4197-80A8-37FA8069AA88Q36335946-29C05CF8-30E9-4520-9BAD-B467A6C24187Q36707350-6ED4A3BE-7242-4FAF-ABC3-E0A4CA3C6B86Q38126375-14632F2E-7BD3-4D02-B09C-0A567321A197Q38266846-E466CE90-03D8-4FDB-99C9-DD531714F697Q38777309-80C46008-29B5-44AC-9DE0-AF5AE7B88613Q39027923-4BA6DEEF-3466-40DE-B47A-4FD3CCEE73F7Q39329851-C15BF880-5D3F-4ABF-9DBF-5D9196B92687Q39706971-4EBE5681-84AE-43FC-A6EA-6CA70C2274E8Q39966356-D3832110-5890-4AFA-8E5A-928258716146Q41251229-6350BF1D-559B-4D81-93BD-41C9D23E1316Q46961094-27E26447-6C52-447A-BA12-3B4BC98F6535Q55037970-CA8B40AB-E88A-45F7-B59C-93701044ABC7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A pilot randomized controlled trial of deprescribing.
@ast
A pilot randomized controlled trial of deprescribing.
@en
type
label
A pilot randomized controlled trial of deprescribing.
@ast
A pilot randomized controlled trial of deprescribing.
@en
prefLabel
A pilot randomized controlled trial of deprescribing.
@ast
A pilot randomized controlled trial of deprescribing.
@en
P2093
P2860
P356
P1476
A pilot randomized controlled trial of deprescribing.
@en
P2093
Alasdair Millar
Christopher Beer
Kathleen Potter
Poh-Kooi Loh
Yan Gee Peng
P2860
P356
10.1177/2042098611400332
P577
2011-04-01T00:00:00Z